2018
DOI: 10.1016/j.jdermsci.2018.08.012
|View full text |Cite
|
Sign up to set email alerts
|

Ethyl 2,4-dicarboethoxy pantothenate, a derivative of pantothenic acid, prevents cellular damage initiated by environmental pollutants through Nrf2 activation

Abstract: EDCEP reduces cellular damage initiated by environmental pollutants by stimulating the intracellular defense system against ROS through the activation of Nrf2, and by interfering with AHR signaling pathway activation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 27 publications
0
9
0
Order By: Relevance
“…Upon binding to its ligand, the AhR translocates from the cytoplasm to the nucleus, where it forms a dimer with the AhR nuclear translocator (ARNT) [202]. PM induces the nuclear translocation of AhR in vitro [119,124,171,172,178]. The AhR/ARNT complex binds to conserved promoter regions containing the xenobiotic response element (XRE), promoting the transcription of several groups of target genes, such as from the phase I metabolism (e.g., cytochrome P450 family 1 subfamily A member 1, CYP1A1, CYP1A2, and CYP1B1), the phase II metabolism (e.g., UDP glucuronosyltransferase family 1 member A complex locus, UGT1A and glutathione S-transferase A1, GSTA1) and a gene for the arylhydrocarbon receptor repressor (AhRR) [203].…”
Section: Pm Triggers Exogenous and Endogenous Ros Formationmentioning
confidence: 99%
See 2 more Smart Citations
“…Upon binding to its ligand, the AhR translocates from the cytoplasm to the nucleus, where it forms a dimer with the AhR nuclear translocator (ARNT) [202]. PM induces the nuclear translocation of AhR in vitro [119,124,171,172,178]. The AhR/ARNT complex binds to conserved promoter regions containing the xenobiotic response element (XRE), promoting the transcription of several groups of target genes, such as from the phase I metabolism (e.g., cytochrome P450 family 1 subfamily A member 1, CYP1A1, CYP1A2, and CYP1B1), the phase II metabolism (e.g., UDP glucuronosyltransferase family 1 member A complex locus, UGT1A and glutathione S-transferase A1, GSTA1) and a gene for the arylhydrocarbon receptor repressor (AhRR) [203].…”
Section: Pm Triggers Exogenous and Endogenous Ros Formationmentioning
confidence: 99%
“…CYP enzymes can metabolize PAHs, and the formed metabolites can induce cell damage either by the formation of DNA, protein adducts, or the generation of ROS [195,[204][205][206][207][208]. Indeed, PM upregulates the CYP enzyme mRNA and protein expression in vitro and in vivo [119,128,129,134,135,139,141,167,171,172,178,187]. Other ROS producing enzymes are the members of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) family [209].…”
Section: Pm Triggers Exogenous and Endogenous Ros Formationmentioning
confidence: 99%
See 1 more Smart Citation
“…Nrf2‐activating compounds are becoming staple ingredients in topically applied skin‐conditioning creams and other formulations that mitigate skin damage (Ahmed, ; Ben‐Nun, ; Braidy et al, ; Burke, ; Davinelli, Nielsen, & Scapagnini, ; Gorini et al, ; Huang, Wang, Yang, Chou, & Fang, ; Kocot, Kiełczykowska, Luchowska‐Kocot, Kurzepa, & Musik, ; Kunnumakkara et al, ; Lephart, ; Ríos, Giner, Marín, & Recio, ; Rodríguez‐Luna et al, ; Simitzis, ; Vega et al, , ; Vollmer et al, ; Yang et al, ; Yokota, Yahagi, & Masaki, ), promote skin repair (Bellot et al, ; Davinelli, Nielsen, & Scapagnini, ; Ferreira & Gomes, ; Kim et al, ; Yang et al, ), and enhance diabetic‐associated wound healing (Bellot et al, ; Ben‐Nun, ; Cuadrado et al, ; Ferreira & Gomes, ; Gorini et al, ; Huang et al, ; Kim et al, ; Kocot et al, ; Kunnumakkara et al, ; Panahi et al, ; Ríos et al, ; Sanchez, Lancel, Boulanger, & Neviere, ; Vega et al, ; Vega et al, ; Vollmer et al, ). With respect to the latter, almost a third of the world's population is considered to be overweight or obese (González‐Muniesa et al, ) and the percentage is rising to epidemic proportions (Blaszczak et al, ; Severin, Sabbahi, Mahmoud, Arena, & Phillips, ).…”
Section: Nrf2‐activating Therapeuticsmentioning
confidence: 99%
“…Nrf2-activating compounds are becoming staple ingredients in topically applied skin-conditioning creams and other formulations that mitigate skin damage (Ahmed, 2019;Ben-Nun, 2018;Braidy et al, 2019;Burke, 2018;Davinelli, Nielsen, & Scapagnini, 2018;Gorini et al, 2019;Huang, Wang, Yang, Chou, & Fang, 2018;Kocot, Kiełczykowska, Luchowska-Kocot, Kurzepa, & Musik, 2018;Kunnumakkara et al, 2017;Lephart, 2018;Ríos, Giner, Marín, & Recio, 2018;Rodríguez-Luna et al, 2018;Simitzis, 2018;Vega et al, 2017Vega et al, , 2018Vollmer et al, 2018;Yokota, Yahagi, & Masaki, 2018), promote skin repair (Bellot et al, 2019;Davinelli, Nielsen, & Scapagnini, 2018;Ferreira & Gomes, 2018;, and enhance diabeticassociated wound healing (Bellot et al, 2019;Ben-Nun, 2018;Cuadrado et al, 2019;Ferreira & Gomes, 2018;Gorini et al, 2019;Huang et al, 2018;Kocot et al, 2018;Kunnumakkara et al, 2017;Panahi et al, 2019;Ríos et al, 2018;Sanchez, Lancel, Boulanger, & Neviere, 2018;Vega et al, 2017;Vega et al, 2018;Vollmer et al, 2018).…”
Section: Contributing To the Difficulty In Designing A Clinically Viablementioning
confidence: 99%